In one of the most recent developments the NHS will now be made available with a bi-yearly jab for the painful and crippling done disease called osteoporosis.
The drug rationing body ‘Nice’ said that women going through their post-menopausal stage having a high risk of fractures should now be treated with a drug called Prolia in case other alternative treatments are not suitable.
Several drug trials have been conducted on women to show that it dramatically reduces the number of spine and hip fractures and also helps to reduce bones to grow once again. A new and cheap alternative of a bi-yearly injection for osteoporosis is going to be made available on the NHS.
“I am delighted that NICE has made the decision to give patients access to this convenient and effective treatment option,” said Dr Alun Cooper, a GP in Crawley, West Sussex.
An estimate of approximately 170,000 women per year are not able to bisphosphonates and take the risk of getting their bones spoil the condition more than the treatment.
Good News USA
- AT&T closes its $1.2 billion acquisition of Leap Wireless
- Verizon announces new AllSet prepaid plans with rollover feature
- AT&T selects two trial locations to transition landline customers away from copper wire line
- Vodafone Foundation launches Instant Network Mini ‘mobile network in a backpack’
- Brunswick and South Morang phone and Internet users being urged to switch to NBN